You are using an outdated browser. Please upgrade your browser to improve your experience.

trastuzumab deruxtecan

Ligand Summary
Fam-trastuzumab deruxtecan-nxki is a HER2-directed antibody-drug conjugate. The antibody is a humanized anti-HER2 IgG1. The small molecule, DXd, is a topoisomerase I inhibitor attached to the antibody by a cleavable linker. Following binding to HER2 on tumor cells, fam-trastuzumab deruxtecan-nxki undergoes internalization and intracellular linker cleavage by lysosomal enzymes. Upon release, the membrane-permeable DXd causes DNA damage and apoptotic cell death.
Synonyms & Links
DrugCentral: 5367
LyCHI:  trastuzumab deruxtecan

Target Activities